ArticleJournal of cancer research and clinical oncology2014

Bispecific Her2 × cotinine antibody in combination with cotinine-(histidine)2-iodine for the pre-targeting of Her2-positive breast cancer xenografts.

Soomin Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.